Jung KW, Won YJ, Hong S, Kong HJ, Im JS, Seo HG. Prediction of cancer incidence and mortality in Korea, 2021. Cancer Res Treat. 2021;53:316–22.
Article PubMed PubMed Central Google Scholar
Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202–9.
Chia NY, Tan P. Molecular classification of gastric cancer. Ann Oncol. 2016;27:763–9.
Ning S. Innate immune modulation in EBV infection. Herpesviridae. 2011;2:1.
Article CAS PubMed PubMed Central Google Scholar
IARC (1997) Epstein-Barr virus and Kaposi’s sarcoma herpesvirus/human herpesvirus 8, IARC, Lyon, France. pp. 47–262.
Tsao SW, Tsang CM, To KF, Lo KW. The role of Epstein-Barr virus in epithelial malignancies. J Pathol. 2015;235:323–33.
Article CAS PubMed Google Scholar
Chen XZ, Chen H, Castro FA, Hu JK, Brenner H. Epstein-Barr virus infection and gastric cancer: a systematic review. Medicine (Baltimore). 2015;94: e792.
Article CAS PubMed Google Scholar
Burke AP, Yen TS, Shekitka KM, Sobin LH. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol. 1990;3:377–80.
Bae JM, Kim EH. Epstein-Barr virus and gastric cancer risk: a meta-analysis with meta-regression of case-control studies. J Prev Med Public Health. 2016;49:97–107.
Article PubMed PubMed Central Google Scholar
Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015;21:449–56.
Article CAS PubMed Google Scholar
Naseem M, Barzi A, Brezden-Masley C, Puccini A, Berger MD, Tokunaga R, et al. Outlooks on Epstein-Barr virus associated gastric cancer. Cancer Treat Rev. 2018;66:15–22.
Article CAS PubMed PubMed Central Google Scholar
Kim YS, Nam SC, Han MH, Jeong JY, Park SK, Suh IS, et al. Predictive factors of Epstein-Barr virus association in gastric adenocarcinoma. Korean J Pathol. 2008;42:193–7.
Camargo MC, Kim KM, Matsuo K, Torres J, Liao LM, Morgan DR, et al. Anti-Helicobacter pylori antibody profiles in Epstein-Barr virus (EBV)- positive and EBV-negative gastric cancer. Helicobacter. 2016;21:153–7.
Article CAS PubMed Google Scholar
van Beek J, Zur Hausen A, Klein Kranenbarg E, van de Velde CJ, Middeldorp JM, van den Brule AJ, et al. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. J Clin Oncol. 2004;22:664–70.
Li S, Du H, Wang Z, Zhou L, Zhao X, Zeng Y. Meta-analysis of the relationship between Epstein-Barr virus infection and clinicopathological features of patients with gastric carcinoma. Sci China Life Sci. 2010;53:524–30.
Murphy G, Pfeiffer R, Camargo MC, Rabkin CS. Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology. 2009;137:824–33.
Kijima Y, Ishigami S, Hokita S, Koriyama C, Akiba S, Eizuru Y, et al. The comparison of the prognosis between Epstein-Barr virus (EBV)-positive gastric carcinomas and EBV-negative ones. Cancer Lett. 2003;200:33–40.
Article CAS PubMed Google Scholar
Camargo MC, Koriyama C, Matsuo K, Kim WH, Herrera-Goepfert R, Liao LM, et al. Case-case comparison of smoking and alcohol risk associations with Epstein-Barr virus-positive gastric cancer. Int J Cancer. 2014;134:948–53.
Article CAS PubMed Google Scholar
Kayamba V, Monze M, Asombang AW, Zyambo K, Kelly P. Serological response to Epstein-Barr virus early antigen is associated with gastric cancer and human immunodeficiency virus infection in Zambian adults: a case-control study. Pan Afr Med J. 2016;23:45.
Article PubMed PubMed Central Google Scholar
Ignatova E, Seriak D, Fedyanin M, Tryakin A, Pokataev I, Menshikova S, et al. Epstein-Barr virus-associated gastric cancer: disease that requires special approach. Gastric Cancer. 2020;23:951–60.
Kim HJ, Hwang SW, Kim N, Yoon H, Shin CM, Park YS, et al. Helicobacter pylori and molecular markers as prognostic indicators for gastric cancer in Korea. J Cancer Preven. 2014;19:56–67.
Lee JH, Kim SH, Han SH, An JS, Lee ES, Kim YS. Clinicopathological and molecular characteristics of Epstein-Barr virus associated gastric carcinoma: a meta-analysis. J Gastroenterol Hepatol. 2009;24:354–65.
Tokunaga M, Land CE. Epstein-Barr virus involvement in gastric cancer: biomarker for lymph node metastasis. Cancer Epidemiol Biomarkers Prev. 1998;7:449–50.
Camargo MC, Kim WH, Chiaravalli AM, Kim KM, Corvalan AH, Matsuo K, et al. Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut. 2014;63:236–43.
Tokunaga M, Uemura Y, Tokudome T, Ishidate T, Masuda H, Okazaki E, et al. Epstein-Barr virus related gastric cancer in Japan: a molecular patho-epidemiological study. Acta Pathol Jpn. 1993;43:574–81.
Sohn BH, Hwang JE, Jang HJ, Lee HS, Oh SC, Shim JJ, et al. Clinical significance of four molecular subtypes of gastric cancer identified by the cancer genome atlas project. Clin Cancer Res. 2017;23:4441–9.
Article CAS PubMed PubMed Central Google Scholar
Uemura Y, Tokunaga M, Arikawa J, Yamamoto N, Hamasaki Y, Tanaka S, et al. A unique morphology of Epstein-Barr virus related early gastric carcinoma. Cancer Epidemiol Biomarkers Prev. 1994;3:607–11.
Song HJ, Srivastava A, Lee J, Kim YS, Kim KM, Ki Kang W, et al. Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma. Gastroenterology. 2010;139:84-92.e2.
Choi Y, Kim N, Kim KW, Jo HH, Park J, Yoon H, et al. Sex-based differences in histology, staging, and prognosis among 2983 gastric cancer surgery patients. World J Gastroenterol. 2022;28:933–47.
Article CAS PubMed PubMed Central Google Scholar
Jung YJ, Kim HJ, Park CH, Park SJ, Kim N. Effects of reproductive factors on Lauren intestinal-type gastric cancers in females: a multicenter retrospective study in South Korea. Gut Liver. 2022;16:706–15.
Article PubMed PubMed Central Google Scholar
Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626–38.
Article CAS PubMed Google Scholar
Araujo JM, Rosas G, Belmar-López C, Raez LE, Rolfo CD, Schwarz LJ, et al. Influence of sex in the molecular characteristics and outcomes of malignant tumors. Front Oncol. 2021;19(11): 752918.
Tokunaga M, Land CE, Uemura Y, Tokudome T, Tanaka S, Sato E. Epstein-Barr virus in gastric carcinoma. Am J Pathol. 1993;143:1250–4.
CAS PubMed PubMed Central Google Scholar
Park JH, Kim EK, Kim YH, Kim JH, Bae YS, Lee YC, et al. Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa invasive early gastric cancer. Gastric Cancer. 2016;19:1041–51.
Article CAS PubMed Google Scholar
Cheng Y, Zhou X, Xu K, Huang J, Huang Q. Very low risk of lymph node metastasis in Epstein-Barr virus-associated early gastric carcinoma with lymphoid stroma. BMC Gastroenterol. 2020;20:273.
Article CAS PubMed PubMed Central Google Scholar
Lim H, Lee IS, Lee JH, Park YS, Kang HJ, Na HK, et al. Clinical application of early gastric carcinoma with lymphoid stroma based on lymph node metastasis status. Gastric Cancer. 2017;20:793–801.
Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res. 2004;10:803–21.
Article CAS PubMed Google Scholar
Watanabe H, Enjoji M, Imai T. Gastric carcinoma with lymphoid stroma. Its morphologic characteristics and prognostic correlations. Cancer. 1976;38:232–43.
Article CAS PubMed Google Scholar
Tak DH, Jeong HY, Seong JK, Moon HS, Kang SH. Comparison of clinical characteristics and prognostic factors between gastric lymphoepithelioma-like carcinoma and gastric adenocarcinoma. Korean J Gastroenterol. 2013;62:272–7.
Kang BW, Seo AN, Yoon S, Bae HI, Jeon SW, Kwon OK, et al. Prognostic value of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric cancer. Ann Oncol. 2016;27:494–501.
留言 (0)